Synthesis, Antimicrobial Assay and SARs of Pyrazole Included Heterocyclic Derivatives

References

• (a) H. Miller, D.G. Barceloux, E.P. Krenzelok, K. Olson and W. Watson, “American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene glycol Poisoning.” Journal of Toxicology: Clinical toxicology 37, (1999): 537–560. (b) D.G. Barceloux, G.B. Randall, E.P. Krenzelok, H. Cooper and J.V. Allister, “American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Methanol Poisoning.” Journal of Toxicology: Clinical Toxicology 40, (2002): 415–446.
   PubMed Web of Science ®Google Scholar
• A. Masunari, and L. C. Tavares, “A New Class of Nifuroxazide Analogues: synthesis of 5-Nitrothiophene Derivatives with Antimicrobial Activity against Multidrug-Resistant Staphylococcus aureus,” Bioorganic & Medicinal Chemistry 15, no. 12 (2007): 4229–36.
   PubMed Web of Science ®Google Scholar
• A. Mittal, L. Kurup, and J. Mittal, “Freundlich and Langmuir Adsorption Isotherms and Kinetics for the Removal of Tartrazine from Aqueous Solutions Using Hen Feathers,” Journal of Hazardous Materials 146, no. 1-2 (2007): 243–8.
   PubMed Web of Science ®Google Scholar
• G. G. Zhanel, P. Chung, H. Adam, S. Zelenitsky, A. Denisuik, F. Schweizer, P. R. S. Lagacé-Wiens, E. Rubinstein, A. S. Gin, A. Walkty, et al. “Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination with Activity against Multidrug-Resistant Gram-Negative Bacilli,” Drugs 74, no. 1 (2014): 31–51.,.
   PubMed Web of Science ®Google Scholar
• S. M. H. Sanad, D. H. Hanna, and A. E. M. Mekky, “Regioselective Synthesis of Novel Antibacterial Pyrazole-Benzofuran Hybrids: 2D NMR Spectroscopy Studies and Molecular Docking,” Journal of Molecular Structure 1188, (2019): 214–26.
   Web of Science ®Google Scholar
• J. Nalawade, A. Shinde, A. Chavan, S. Patil, M. Suryavanshi, M. Modak, P. Choudhari, V. D. Bobade, and P. C. Mhaske, “Synthesis of New Thiazolyl-Pyrazolyl-1,2,3-Triazole Derivatives as Potential Antimicrobial Agents,” European Journal of Medicinal Chemistry 179, (2019): 649–59.
   PubMed Web of Science ®Google Scholar
• T. Y. Zhang, C. J. Zheng, J. Wu, L. P. Sun, and H. R. Piao, “Synthesis of Novel Dihydrotriazine Derivatives Bearing 1,3-Diaryl pyrazole Moieties as Potential Antibacterial Agents ,”Bioorganic & Medicinal Chemistry Letters 29, no. 9 (2019): 1079–84.
   PubMed Web of Science ®Google Scholar
• (a) D.M. Omran, M.A. Ghaly, S.M. El-Messery, F.A. Badria, E. Abdel-Latif and I.A. Shehata, "Targeting Hepatocellular Carcinoma: Synthesis of New Pyrazole-Based Derivatives, Biological Evaluation, DNA Binding, and Molecular Modeling Studies." Bioorganic Chemistry 88, (2019): 102917. (b) V. Padmavathi, C. Prema kumari, B.C. Venkatesh, A. Padmaja, “Synthesis and Antimicrobial Activity of Amido Linked Pyrrolyl and Pyrazolyl-oxazoles, Thiazoles and imidazoles.” European Journal of Medicinal Chemistry 46, (2011): 5317–5326. (c) A. Muralikrishna, B.C. Venkatesh, V. Padmavathi, A. Padmaja, P. Kondaiah, N. Siva Krishna, “Synthesis, Antimicrobial and Cytotoxic Activities of Sulfone Linked bis Heterocycles.” European Journal of Medicinal Chemistry 54, (2012): 605–614.
   PubMed Web of Science ®Google Scholar
• M. Alam, O. Alam, S. Khan, M. Naim, M. Islamuddin, and G. S. Deora, “Synthesis, anti-Inflammatory, Analgesic, COX1/2-Inhibitory Activity, and Molecular Docking Studies of Hybrid Pyrazole Analogues,” Drug Design, Development and Therapy 10, (2016): 3529–43.
   PubMed Web of Science ®Google Scholar
• S. J. Gawandi, V. G. Desai, and S. G. Shingade, “Design, Synthesis, and Biological Evaluation of 1,3,5-Trisubstituted Pyrazoles as Tyrosine Kinase Inhibitors,” Medicinal Chemistry Research 28, no. 3 (2019): 267–78.
   Web of Science ®Google Scholar
• (a) L.D. Khillare, M.R. Bhosle, A.R. Deshmukh and R.A. Mane, "Synthesis and Anti-Inflammatory Evaluation of New Pyrazoles Bearing Biodynamic Thiazole and Thiazolidinone Scaffolds." Medicinal Chemistry Research 24, (2015): 1380–1386. (b) B.C. Venkatesh, C. Prema kumari, A. Padmaja and V. Padmavathi, “Polarized Ketene Dithioacetals-Versatile Synthons for Different Heterocycles.” Chinese Journal of Chemistry 30, (2012): 1886–1892. (c) A. Padmaja, C. Rajasekhar, S. Durgamma, B.C. Venkatesh and V. Padmavathi, “Synthesis and Antioxidant Activity of Pyrazolyl-oxazolines/thiazolines and Isoxazolyl-oxazolines/thiazolines.” Medicinal Chemistry Research 23, (2014): 1084–1098. 10.1007/s00044-013-0688-z.
   Web of Science ®Google Scholar
• (a) A. Dandia, D. Saini, S. Bhaskaran and D.K. Saini, "Ultrasound Promoted Green Synthesis of spiro[pyrano[2,3-c]pyrazoles] as Antioxidant Agents." Medicinal Chemistry Research 23, (2014): 725–734.
   Web of Science ®Google Scholar
  (b) V. Padmavathi, B.C. Venkatesh, A. Muralikrishna, A. Padmaja, “The Reactivity of Gem Cyanoester Ketene Dithiolates towards the Development of Potent Antioxidant Heterocycles.” Chemical and Pharmaceutical Bulletin 60 (2012): 449–458.
   PubMed Web of Science ®Google Scholar
  (c) V. Padmavathi, B.C. Venkatesh, A. Muralikrishna, A. Padmaja, “Synthesis and Antioxidant Activity of a New Class of Bis and Tris Heterocycles.” Archive der Pharmazie 345, (2012): 745–752.
   PubMed Web of Science ®Google Scholar
• M. Abdel-Aziz, G. A. Abuo-Rahma, and A. A. Hassan, “Synthesis of Novel Pyrazole Derivatives and Evaluation of Their Antidepressant and Anticonvulsant Activities,” European Journal of Medicinal Chemistry 44, no. 9 (2009): 3480–7.
   PubMed Web of Science ®Google Scholar
• P. D. Gokulan, B. Jayakar, V. Alagarsamy, and V. S. Raja, “Synthesis and Pharmacological Investigation of 5-Substituted-3-Methylsulfanyl-1H-Pyrazole-4-Carboxylic Acid Ethyl Esters as New Analgesic and Anti-inflammatory Agents ,” Arzneimittel-Forschung 62, no. 10 (2012): 457–62.
   PubMed Web of Science ®Google Scholar
• H. M. Faidallah, K. A. Khan, and A. M. Asiri, “Synthesis and Biological Evaluation of New 3-Trifluoromethylpyrazolesulfonyl-Urea and Thiourea Derivatives as Antidiabetic and Antimicrobial Agents,” Journal of Fluorine Chemistry 132, no. 2 (2011): 131–7.
   Web of Science ®Google Scholar
• G. M. Reddy, J. R. Garcia, V.H. Reddy, A. M. de Andrade, A. Camilo, R. A. Pontes Ribeiro, and S. R. de Lazaro, “Synthesis, Antimicrobial Activity and Advances in Structure-Activity Relationships (SARs) of Novel Tri-Substituted Thiazole Derivatives,” European Journal of Medicinal Chemistry 123, (2016): 508–13.
   PubMed Web of Science ®Google Scholar
• G. M. Reddy, J. R. Garcia, G. V. Zyryanov, G. Sravya, and N. B. Reddy, “Pyranopyrazoles as Efficient Antimicrobial Agents: green, One Pot and Multicomponent Approach,” Bioorganic Chemistry 82, (2019): 324–31.
   PubMed Web of Science ®Google Scholar
• G. M. Reddy, and J. R. Garcia, “Synthesis of Pyranopyrazoles under Eco‐Friendly Approach by Using Acid Catalysis,” Journal of Heterocyclic Chemistry 54, no. 1 (2017): 89–94.
   Web of Science ®Google Scholar
• J. O'Neill, R. Minghui, N. Kuo, S. Chaudhry, M.W. Bonney, S. Solomon, J.K. Hamied, M.O. Moraes and E. Goosby, “Tackling Drug-resistant Infections Globally: Final Report and Recommendations.” 2016. https://amr-review.org/.
   Google Scholar
• World Health Organization (WHO). Global Action Plan on Antimicrobial Resistance, 2015. http://www.who.int/antimicrobial-resistance/globalaction-plan/en/.
   Google Scholar
• U. Theuretzbacher, “Accelerating Resistance, Inadequate Antibacterial Drug Pipelines and International Responses,” International Journal of Antimicrobial Agents 39, no. 4 (2012): 295–9.
   PubMed Web of Science ®Google Scholar
• M. Zasloff, “Antimicrobial Peptides of Multicellular Organisms,” Nature 415, no. 6870 (2002): 389–95.
   PubMed Web of Science ®Google Scholar
• B. Spellberg, J. H. Powers, E. P. Brass, L. G. Miller, and J. E. Edwards, Jr., “Trends in Antimicrobial Drug Development: Implications for the Future,” Clinical Infectious Diseases 38, no. 9 (2004): 1279–86.
   PubMed Web of Science ®Google Scholar
• S. B. Levy, and B. Marshall, “Antibacterial Resistance Worldwide: Causes, Challenges and Responses,” Nature Medicine 10, no. S12 (2004): S122–S129.
   PubMedGoogle Scholar
• S. H. Park, “Third-Generation Cephalosporin Resistance in Gram-Negative Bacteria in the Community: A Growing Public Health Concern,” The Korean Journal of Internal Medicine 29, no. 1 (2014): 27–30.
   PubMed Web of Science ®Google Scholar
• L. S. Redgrave, S. B. Sutton, M. A. Webber, and L. Piddock, “Fluoroquinolone Resistance: Mechanisms, Impact on Bacteria, and Role in Evolutionary Success,” Trends in Microbiology 22, no. 8 (2014): 438–45.
   PubMed Web of Science ®Google Scholar
• L. S. Munoz-Price, L. Poirel, R. A. Bonomo, M. J. Schwaber, G. L. Daikos, M. Cormican, G. Cornaglia, J. Garau, M. Gniadkowski, M. K. Hayden, et al. “Clinical Epidemiology of the Global Expansion of Klebsiella pneumoniae Carbapenemases,” The Lancet. Infectious Diseases 13, no. 9 (2013): 785–96.
   PubMed Web of Science ®Google Scholar
• J. W. Costerton, P. S. Stewart, and E. P. Greenberg, “Bacterial Biofilms: A Common Cause of Persistent Infections,” Science (New York, N.Y.) 284, no. 5418 (1999): 1318–22.
   PubMed Web of Science ®Google Scholar
• G. Cabot, L. Zamorano, B. Moyà, C. Juan, A. Navas, J. Blázquez, and A. Oliver, “Evolution of Pseudomonas aeruginosa Antimicrobial Resistance and Fitness under Low and High Mutation Rates,” Antimicrobial Agents and Chemotherapy 60, no. 3 (2016): 1767–78.
   PubMed Web of Science ®Google Scholar
• A. Voss, and B. N. Doebbeling, “The Worldwide Prevalence of Methicillin-Resistant Staphylococcus aureus,” International Journal of Antimicrobial Agents 5, no. 2 (1995): 101–6.
   PubMed Web of Science ®Google Scholar
• P. D. Stapleton, and P. W. Taylor, “Methicillin Resistance in Staphylococcus aureus: mechanisms and Modulation,” Science Progress 85, no. 1 (2002): 57–72.
   PubMedGoogle Scholar
• B. Parrino, D. Schillaci, I. Carnevale, E. Giovannetti, P. Diana, G. Cirrincione, and S. Cascioferro, “Synthetic Small Molecules as anti-Biofilm Agents in the Struggle against Antibiotic Resistance,” European Journal of Medicinal Chemistry 161, (2019) : 154–78.
   PubMed Web of Science ®Google Scholar
• L. Sobotta, P. Skupin-Mrugalska, J. Piskorz, and J. Mielcarek, “Porphyrinoid Photosensitizers Mediated Photodynamic Inactivation against Bacteria,” European Journal of Medicinal Chemistry 175, (2019): 72–106.
   PubMed Web of Science ®Google Scholar
• (a) D. Schillaci, V. Spanò, B. Parrino, A. Carbone, A. Montalbano, P. Barraja, P. Diana, G. Cirrincione and S. Cascioferro, "Pharmaceutical Approaches to Target Antibiotic Resistance Mechanisms." Journal of Medicinal Chemistry 60, (2017): 8268–8297. (b) R.K.C. Charles, B.C. Venkatesh, W.K. Mokone, A.L. Rousseau, D. Brady, M.A. Fernandes and M.L. Bode, “Efficient One-pot Synthesis of Functionalized Imidazo[1,2-a]pyridines and Unexpected Synthesis of Novel Tetracyclic Derivatives by Nucleophilic Aromatic Substitution.” RSC Advances 10, (2020): 8104–8114.
   PubMed Web of Science ®Google Scholar
• N. Jackson, L. Czaplewski, and L. J. V. Piddock, “Discovery and Development of New Antibacterial Drugs: learning from Experience?” Journal of Antimicrobial Chemotherapy 73, no. 6 (2018): 1452–9.
   PubMed Web of Science ®Google Scholar
• M. Koca, A. S. Ertürk, and A. Umaz, “Microwave-Assisted Intermolecular Aldol Condensation: Efficient One-Step Synthesis of 3-Acetyl Isocoumarin and Optimization of Different Reaction Conditions,” Arabian Journal of Chemistry 11, no. 4 (2018): 538–45.
   Web of Science ®Google Scholar
• G.M. Reddy, J.R. Garcia, G. Yuvaraja, M.V. Subbiah and J.-C. Wen, "Design, Synthesis of tri‐substituted Pyrazole Derivatives as Promising Antimicrobial Agents and Investigation of Structure Activity Relationships." Journal of Heterocyclic Chemistry 57, (2020): 2288–2296.
   Google Scholar